Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
Clinical trial NCT05285137 · COMPLETED
Trial details
- NCT number
- NCT05285137
- Sponsor
- Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-10-27
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.